Castle Biosciences, Inc. · NASDAQ:CSTL
Juvenal Tobin W sold 3,195 Castle Biosciences, Inc. shares (Form 4)
Traded Nov 11, 2026 · Filed Nov 13, 2026
On Nov 11, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 3,195 Castle Biosciences, Inc. shares at US$35.07 for US$112K, leaving 32,737 shares. Filed Nov 13, 2026 (Form 4).
- Sold
- 3,195 shares
- Price
- US$35.07
- Value
- US$112K
- Holding after
- 32,737 shares
- Trading plan
- No
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Common Stock | Option exercise | 3,195 | US$29.50 | 35,932 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 3,195 | US$35.07 | 32,737 | Direct |
Source
Download original · View original at SEC
Related
- Castle Biosciences, Inc.
- Juvenal Tobin W
- Castle Biosciences, Inc. shareholders
- Form 4 · Juvenal Tobin W · Nov 12, 2026
- Form 4 · Juvenal Tobin W · Oct 30, 2026
- Form 4 · Juvenal Tobin W · Oct 28, 2026
- Form 4 · Juvenal Tobin W · Oct 14, 2026
- Form 4 · Juvenal Tobin W · Oct 1, 2026
- Form 4 · Bradbury Daniel · Nov 19, 2026
- Form 4 · Maetzold Derek J · Nov 18, 2026
- Form 4 · Maetzold Derek J · Nov 4, 2026
- Schedule 13G/A · Principal Global Investors · Oct 29, 2026
- Form 4 · Maetzold Derek J · Oct 21, 2026